Lexicon Pharmaceuticals | Ventes





Ventes Changement Date
Abbott USD 11.46B 90M 2025-12
Acadia Pharmaceuticals USD 278.6M 14M 2025-09
Agios Pharmaceuticals USD 12.9M 450K 2025-09
Akebia Therapeutics USD 57.34M 10.84M 2025-03
Alnylam Pharmaceuticals USD 1.25B 476.31M 2025-09
AstraZeneca USD 15.5B 313M 2025-12
BioMarin Pharmaceutical USD 776M 49M 2025-09
Coherus Biosciences USD 7.6M 46.54M 2025-03
Eli Lilly USD 19.3B 1.7B 2025-12
Esperion Therapeutics USD 51.63M 22.2M 2024-09
Halozyme Therapeutics USD 354M 148M 2025-09
Illumina USD 1.16B 80M 2025-12
Insmed USD 142M 34.6M 2025-09
Ironwood Pharmaceuticals USD 122.06M 36.82M 2025-09
J&J USD 24.6B 610M 2025-12
Lexicon Pharmaceuticals USD 1.65M 520K 2024-06
MacroGenics USD 72.84M 50.6M 2025-09
MannKind USD 82.13M 5.6M 2025-09
Merck USD 16.4B 880M 2025-12
Moderna USD 1.02B 878M 2025-09
Novartis USD 13.91B 144M 2025-09
PTC Therapeutics USD 211M 32.1M 2025-09
Puma Biotechnology USD 80.54M 33.46M 2024-09
Sarepta Therapeutics USD 399.4M 211.69M 2025-09
Thermo Fisher Scientific USD 12.21B 1.09B 2025-12
Ultragenyx Pharmaceutical USD 160M 6.5M 2025-09
United Therapeutics USD 799.5M 900K 2025-09
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12


Lexicon Pharmaceuticals Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.